Navigation Links
TriMix Laboratories Announces New TriMix-gel Partnership with US Compounding
Date:2/5/2013

(PRWEB) February 05, 2013

TriMix Laboratories LLC today announced it has entered into an agreement with US Compounding, INC as the exclusive pharmacy for prescription fulfillment of TriMix-gel®. TriMix-gel has been prescribed by doctors as both a first line and secondary treatment for erectile dysfunction (ED). US Compounding is a licensed compounding pharmacy which makes TriMix-gel for each individual patient in response to a prescription from a licensed physician. For more information on TriMix-gel, visit http://www.TriMixgel.com .

Eddie Glover, US Compounding CEO, said “TriMix-gel is a welcomed addition to our compounding services. Our new 17,000 square foot, state of the art facility can easily accommodate the sophisticated compounding requirements of TriMix-gel and we look forward to greeting our new patients with the same first class quality and service all our customers have come to expect from us.”

T.J. Harkins, President of TriMix Laboratories commented, “We are very pleased to enter into this relationship with US Compounding because of the sheer strength of their superior pharmacy operations. They are a member of the elite pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB) in both sterile and non-sterile compounding. PCAB accreditation means US Compounding has independent outside validation, it meets nationally accepted quality assurance, quality control, and quality improvement standards.”

TriMix-gel uses an all-in-one Easy-GEL™ system and methodology for delivery of the medicine. This innovative system stores, mixes and applies the medicine at time of use. One feature is the medicine in this form does not have to be refrigerated and can be carried by the patient at room temperature. Patients are very happy they no longer need to carry their medicine in an ice pack. Additionally, TriMix-gel uses FDA approved vasodilation components but does not have to be self-injected with a needle.

TriMix-gel contains active ingredients which are classified as medicine and listed in the US Pharmacopeia. Therefore, a patient would need a prescription from his physician to obtain TriMix-gel. For an order form for your doctor, visit http://www.TriMixgel.com and click the prescription form. Give the form to your doctor. He can fax a prescription to US Compounding at 800-448-6996 and the pharmacy will ship the medicine directly to the patient.

TriMix Laboratories LLC is a medical research and marketing firm specializing in urology. For more information, visit http://www.TriMix-gel.com . US Compounding is a recognized leader in pharmaceutical compounding, helping Physicians and Veterinarians with medicine precisely customized for each individual patient. US Compounding maintains federal and state licenses and permits and is registered to dispense in forty nine (49) states. For more information, visit http://www.USCompounding.com .

The information contained herein is general in nature and is intended for use only as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems. TriMix-gel has not been evaluated by the Food and Drug Administration (FDA) and is not made under GMP requirements. It is compounded in a licensed compounding pharmacy accredited by the Compounding Pharmacy Accreditation Board. The compound is for the use of an individual patient who has been prescribed TriMix-gel by a licensed physician. The information contained herein is not intended for making an evaluation as to suitability, risks or benefits. Before taking any action, consult your Physician.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10376035.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Interlinked and InterlinkedTV Announce Heart Test Laboratories Exclusive Interview From NEAA
2. ARUP Laboratories Introduces Blood Test to Aid in the Early Detection of Lung Cancer
3. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
4. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
5. University of Houston Graduate College of Social Work announces partnership with MD Anderson
6. The Ludwig Institute for Cancer Research announces launch of iTeos Therapeutics SA
7. AGA announces prestigious awards recognition recipients
8. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
9. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
10. Zane Benefits Announces Wellness HRAs: A New Way to Reward Healthy Employees
11. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: